Huong T. Le-Petross, M.D., F.R.C.P.C., F.B.S.I.

Peer-Reviewed Articles

1. Shaitelman, SF, Le-Petross, H, Raso, G, Swanson, DM, Schalck, A, Contreras, A, Yang, F, Muruganandham, M, Zhao, GZ, Sawakuchi, GO, Kim, L, Batra, H, Smith, BD, Stauder, MC, Woodward, W, Reddy, JP, Litton, J, Thompson, A, Bedrosian, I, Mittendorf, EA. PRECISE. International Journal of Radiation Oncology Biology Physics 121(1):90-96, 2025. e-Pub 2025. PMID: 39147206.
2. Wang X, Zhao L, Wu X, Krishnamurthy S, Semba T, Shao S, Knafl M, Colfer L W, Alexander A, Vines A, Bopparaju S, Woodward W, Chu R, Zhang J, Yam C, Loo L W M, Nasrazadani A, Le-Petross H, Woodman S, Futreal A, Rare Tumor Initiative Team, Tripathy D. Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer. NPJ Precis Oncol, 2024. e-Pub 2024. PMID: 39558017.
3. Piotrowski a MJ, MY, CL, MT, Kuerer a HM, JL, Hunt a KK, DeSnyder a SM. Optimization of Intraoperative Lumpectomy Specimen Labeling Improves Concordance Between Surgeon and Pathology 1(1), 2024. e-Pub 2024.
4. Nakhlis F, Ueno NT, Troll E, Ryan S, Yeh E, Warren L, Bellon J, Harrison B, Iwase T, Carisa Le-Petross HT, Saleem S, Teshome M, Whitman G, Woodward WA, Overmoyer B, Tolaney SM, Regan M, Lynce F, Layman RM. Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer. Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer, 2023. PMID: 38155272.
5. Panthi B, Mohamed RM, Adrada BE, Boge M, Candelaria RP, Chen H, Hunt KK, Huo L, Hwang K, Korkut A, Lane DL, Le-Petross HC, T Leung JW, Litton JK, Pashapoor S, Perez F, Son JB, Sun J, Thompson A, Tripathy D, Valero V, Wei P, White J, Xu Z, Yang W, Zhou Z, Yam C, Rauch GM, # JM. Early Prediction of Response to Neoadjuvant Systemic Therapy of Triple Negative Breast Cancer using Radiomics on DCE-MRI. Front Oncol 13(eCollection 2023):1-11, 2023. e-Pub 2023.
6. Xu Z, Rauch DE, Mohamed RM, Pashapoor S, Zhou Z, Panthi B, Son JB, Hwang KP, Musall BC, Adrada BE, Candelaria RP, Leung JWT, Le-Petross HTC, Lane DL, Perez F, White J, Clayborn A, Reed B, Chen H, Sun J, Wei P, Thompson A, Korkut A, Huo L, Hunt KK, Litton JK, Valero V, Tripathy D, Yang W, Yam C, Ma J. Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer. Cancers (Basel) 15(19), 2023. e-Pub 2023. PMID: 37835523.
7. Boughey JC, Rosenkranz KM, Ballman KV, McCall L, Haffty BG, Cuttino LW, Kubicky CD, Le-Petross HT, Giuliano AE, Van Zee KJ, Hunt KK, Hahn OM, Carey LA, Partridge AH. Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance). J Clin Oncol 41(17):3184-3193, 2023. e-Pub 2023. PMID: 36977292.
8. Le-Petross HT, Scoggins ME, Clemens MW. Assessment, Complications, and Surveillance of Breast Implants: Making Sense of 2022 FDA Breast Implant Guidance. J Breast Imaging 5(3):360-372, 2023. e-Pub 2023. PMID: 38416893.
9. Panthi B, Adrada BE, Candelaria RP, Guirguis MS, Yam C, Boge M, Chen H, Hunt KK, Huo L, Hwang KP, Korkut A, Lane DL, Le-Petross HC, Leung JWT, Litton JK, Mohamed RM, Musall BC, Pashapoor S, Patel MM, Perez F, Son JB, Thompson A, Valero V, Wei P, White J, Xu Z, Pinsky L, Tripathy D, Yang W, Ma J, Rauch GM. Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI. Cancers (Basel) 15(4), 2023. e-Pub 2023. PMID: 36831368.
10. Panthi B, Mohamed RM, Adrada BE, Boge M, Candelaria RP, Chen H, Hunt KK, Huo L, Hwang KP, Korkut A, Lane DL, Le-Petross HC, Leung JWT, Litton JK, Pashapoor S, Perez F, Son JB, Sun J, Thompson A, Tripathy D, Valero V, Wei P, White J, Xu Z, Yang W, Zhou Z, Yam C, Rauch GM, Ma J. Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Front Oncol 13:1264259, 2023. e-Pub 2023. PMID: 37941561.
11. Breast Imaging EPO, Sanford MF, Slanetz PJ, Lewin AA, Baskies AM, Bozzuto L, Branton SA, Hayward JH, Le-Petross HT, Newell MS, Scheel JR, Sharpe RE, Ulaner GA, Weinstein SP, Moy L. Expert Panel on Breast Imaging, Sanford MF, Slanetz PJ, et al. ACR Appropriateness Criteria® Evaluation of Nipple Discharge: 2022 Update. J Am Coll Radiol. 2022;19(11S):S304-S318. doi:10.1016/j.jacr.2022.09.020. J Am Coll Radiol 11S(11S):S304-S318, 2022. e-Pub 2022. PMID: 36436958.
12. Huang ML, Hess K, Ma J, Santiago L, Scoggins ME, Arribas E, Adrada BE, Le-Petross HT, Leung JWT, Yang W, Geiser W, Candelaria RP. Prospective comparison of synthesized mammography with DBT and full-field digital mammography with DBT uncovers recall disagreements that may impact cancer detection. Acad Radiol 29(7):1039-1045, 2022. e-Pub 2022. PMID: 34538550.
13. Candelaria RP, Adrada BE, Lane DL, Rauch GM, Moulder SL, Thompson AM, Bassett RL, Arribas EM, Le-Petross HT, Leung JWT, Spak DA, Ravenberg EE, White JB, Valero V, Yang WT. Mid-treatment ultrasound descriptors as qualitative imaging biomarkers of pathologic complete response in patients with triple-negative breast cancer. Ultrasound Med Biol 48(6):1010-1018, 2022. e-Pub 2022. PMID: 35300879.
14. Breast Imaging EPO, Le-Petross HT, Slanetz PJ, Lewin AA, Bao J, Dibble EH, Golshan M, Hayward JH, Kubicky CD, Leitch AM, Newell MS, Prifti C, Sanford MF, Scheel JR, Sharpe RE, Weinstein SP, Moy L. ACR Appropriateness Criteria® Imaging of the Axilla. J Am Coll Radiol 19(5S):S87-S113, 2022. e-Pub 2022. PMID: 35550807.
15. Cuttino LW, McCall L, Kubicky C, Ballman KV, Le-Petross H, Hunt KK, Haffty B, Rosenkranz KM, Boughey JC. The feasibility of radiotherapy after breast-conserving surgery for multiple ipsilateral breast cancer: An initial report from ACOSOG Z11102 (Alliance) Trial. Int J Radiat Oncol Biol Phys 112(3):636-642, 2022. e-Pub 2022. PMID: 34634438.
16. Guirguis MS, Adrada BE, Scoggins ME, Moseley TW, Dryden MJ, Le-Petross HC, Rauch GM, Whitman GJ. The challenging image-guided preoperative breast localization: A modality-based approach. AJR Am J Roentgenol 218(3):423-434, 2022. e-Pub 2022. PMID: 34612680.
17. Guirguis MS, Checka C, Adrada BE, Whitman GJ, Dryden MJ, Sun J, Ding QQ, Le-Petross H, Rauch GM, Clemens M, Moseley TW. Bracketing with multiple radioactive seeds to achieve negative margins in breast conservation surgery: Multiple seeds in breast surgery. Clin Breast Cancer 22(2):e158-e166, 2022. e-Pub 2022. PMID: 34187752.
18. Diao K, Andring LM, Barcenas CH, Singh P, Carisa Le-Petross H, Reed VK, Reddy JP, Bloom ES, Ahmad NR, Mayo LL, Perkins GH, Mitchell MP, Nead KT, Tereffe W, Smith BD, Woodward WA. Contemporary outcomes after multimodality therapy in breast cancer patients presenting with ipsilateral supraclavicular node involvement. Int J Radiat Oncol Biol Phys 112(1):66-74, 2022. e-Pub 2022. PMID: 34710521.
19. Patel MM, Le-Petross HT. Baseline FDG PET-CT imaging is necessary for newly diagnosed inflammatory breast cancer patients. Chin Clin Oncol 10(6):56, 2021. e-Pub 2021. PMID: 34806397.
20. Kurlander DE, Le-Petross HT, Shuck JW, Butler CE, Selber JC. Robotic DIEP patient selection: Analysis of CT angiography. Plast Reconstr Surg Glob Open 9(12):e3970, 2021. e-Pub 2021. PMID: 35070606.
21. Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. Contralateral axillary metastasis in patients with inflammatory breast cancer. Ann Surg Oncol 28(13):8610-8621, 2021. e-Pub 2021. PMID: 34125346.
22. Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. ASO visual abstract: Contralateral axillary metastasis in patients with inflammatory breast cancer. Ann Surg Oncol 28(Suppl 3):458-459, 2021. e-Pub 2021. PMID: 34052918.
23. Breast Imaging EPO, Weinstein SP, Slanetz PJ, Lewin AA, Battaglia T, Chagpar AB, Dayaratna S, Dibble EH, Goel MS, Hayward JH, Kubicky CD, Le-Petross HT, Newell MS, Sanford MF, Scheel JR, Vincoff NS, Yao K, Moy L. ACR Appropriateness Criteria® supplemental breast cancer screening based on breast density. J Am Coll Radiol 18(11S):S456-S473, 2021. e-Pub 2021. PMID: 34794600.
24. Balema W, Liu D, Shen Y, El-Zein R, Debeb BG, Kai M, Overmoyer B, Miller KD, Le-Petross HT, Ueno NT, Woodward WA. Inflammatory breast cancer appearance at presentation is associated with overall survival. Cancer Med 10(18):6261-6272, 2021. e-Pub 2021. PMID: 34327874.
25. Musall BC, Abdelhafez AH, Adrada BE, Candelaria RP, Mohamed RMM, Boge M, Le-Petross H, Arribas E, Lane DL, Spak DA, Leung JWT, Hwang KP, Son JB, Elshafeey NA, Mahmoud HS, Wei P, Sun J, Zhang S, White JB, Ravenberg EE, Litton JK, Damodaran S, Thompson AM, Moulder SL, Yang WT, Pagel MD, Rauch GM, Ma J. Functional tumor volume by fast dynamic contrast-enhanced MRI for predicting neoadjuvant systemic therapy response in triple-negative breast cancer. J Magn Reson Imaging 54(1):251-260, 2021. e-Pub 2021. PMID: 33586845.
26. Chung HL, Le-Petross HT, Leung JWT. Imaging updates to breast cancer lymph node management. Radiographics 41(5):1283-1299, 2021. e-Pub 2021. PMID: 34469221.
27. Kida K, Hess KR, Lim B, Iwase T, Chainitikun S, Valero V, Lucci A, Le-Petross HC, Woodward WA, Krishnamurthy S, Hortobagyi GN, Tripathy D, Ueno NT. Validation of prognostic stage and anatomic stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer. Cancers (Basel) 12(11):3105, 2020. e-Pub 2020. PMID: 33114311.
28. Abdelhafez AH, Musall BC, Adrada BE, Hess K, Son JB, Hwang K, Candelaria RP, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, Arribas E, Lane DL, Scoggins ME, T Leung JW, Mahmoud HS, White JB, Ravenberg EE, Litton JK, Valero V, Wei P, Thompson AM, Moulder SL, Pagel MD, Ma J, Yang WT, Rauch GM. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC). Breast Cancer Res Treat 185(1):1-12, 2020. e-Pub 2020.
29. Porembka JH, Ma J, Le-Petross HT. Breast density, MR imaging biomarkers, and breast cancer risk. Breast J 26(8):1535-1542, 2020. e-Pub 2020. PMID: 32654416.
30. Yalniz C, Campbell D, Le-Petross C, Shin K, Bevers TB, Hess KR, Whitman GJ. The role of magnetic resonance imaging in patients with palpable breast abnormalities and negative mammographic and sonographic findings. Breast J 26(7):1289-1295, 2020. e-Pub 2020. PMID: 32108973.
31. DeFazio MV, Arribas EM, Ahmad FI, Le-Petross HT, Liu J, Chu CK, Santiago L, Clemens MW. Application of three-dimensional printed vascular modeling as a perioperative guide to perforator mapping and pedicle dissection during abdominal flap harvest for breast reconstruction. J Reconstr Microsurg 36(5):325-338, 2020. e-Pub 2020. PMID: 32000277.
32. Grant SR, Krishnamurthy S, Le-Petross C, Valero V, Teshome M, Woodward WA. An inflammatory imposter: Three cases of Mullerian carcinoma appearing as inflammatory breast cancer. Breast J 26(5):1022-1024, 2020. e-Pub 2020. PMID: 31960546.
33. Ruiz-Flores L, Whitman GJ, Le-Petross HTC, Hess KR, Parikh JR. Variation in technical quality of breast MRI. Acad Radiol 27(4):468-475, 2020. e-Pub 2020. PMID: 31371208.
34. Breast Imaging EPO, Lewin AA, Moy L, Baron P, Didwania AD, diFlorio-Alexander RM, Hayward JH, Le-Petross HT, Newell MS, Rewari A, Scheel JR, Stuckey AR, Suh WW, Ulaner GA, Vincoff NS, Weinstein SP, Slanetz PJ. ACR Appropriateness Criteria® Stage I Breast Cancer: Initial workup and surveillance for local recurrence and distant metastases in asymptomatic women. J Am Coll Radiol 11S(11S):S428-S439, 2019. e-Pub 2019. PMID: 31685110.
35. Yalniz C, Rosenblat J, Spak D, Wei W, Scoggins M, Le-Petross C, Dryden MJ, Adrada B, Dogan BE. Association of retrospective peer review and positive predictive value of magnetic resonance imaging-guided vacuum-assisted needle biopsies of breast. Eur J Breast Health 15(4):229-234, 2019. e-Pub 2019. PMID: 31620681.
36. Spak DA, Le-Petross HT. Screening modalities for women at intermediate and high risk for breast cancer. Curr Breast Cancer Rep 11(3):111-116, 2019. e-Pub 2019.
37. Eghtedari M, Le-Petross H, Babiera GV, Albarracin CT, Hess KR, Woodtichartpreecha P, Whitman GJ. Not all patients with a diagnosis of a radial scar require excision. Breast J 25(4):792-794, 2019. e-Pub 2019. PMID: 31087426.
38. Raj SD, Agrons MM, Woodtichartpreecha P, Kalambo MJ, Dogan BE, Le-Petross H, Whitman GJ. MRI-guided needle localization: Indications, tips, tricks, and review of the literature. Breast J 25(3):479-483, 2019. e-Pub 2019. PMID: 30924216.
39. Expert Panel on Breast Imaging: Niell BL, Lourenco AP, Moy L, Baron P, Didwania AD, diFlorio-Alexander RM, Heller SL, Holbrook AI, Le-Petross HT, Lewin AA, Mehta TS, Slanetz PJ, Stuckey AR, Tuscano DS, Ulaner GA, Vincoff NS, Weinstein SP, Newell MS. ACR Appropriateness Criteria® evaluation of the symptomatic male breast. J Am Coll Radiol 15(11S):S313-S320, 2018. e-Pub 2018. PMID: 30392600.
40. Breast Imaging: EPO, Holbrook AI, Moy L, Akin EA, Baron P, Didwania AD, Heller SL, Le-Petross HT, Lewin AA, Lourenco AP, Mehta TS, Niell BL, Slanetz PJ, Stuckey AR, Tuscano DS, Vincoff NS, Weinstein SP, Newell MS. ACR Appropriateness Criteria® breast pain. J Am Coll Radiol 15(11S):S276-S282, 2018. e-Pub 2018. PMID: 30392596.
41. Rosenkranz KM, Ballman K, McCall L, Kubicky C, Cuttino L, Le-Petross H, Hunt KK, Giuliano A, Van Zee KJ, Haffty B, Boughey JC. The Feasibility of breast-conserving surgery for multiple ipsilateral breast cancer: An initial report from ACOSOG Z11102 (Alliance) Trial. Ann Surg Oncol 25(10):2858-2866, 2018. e-Pub 2018. PMID: 29987605.
42. Matsuda N, Wang X, Lim B, Krishnamurthy S, Alvarez RH, Willey JS, Parker CA, Song J, Shen Y, Hu J, Wu W, Li N, Babiera GV, Murray JL, Arun BK, Brewster AM, Reuben JM, Stauder MC, Barnett CM, Woodward WA, Le-Petross HTC, Lucci A, DeSnyder SM, Tripathy D, Valero V, Ueno NT. Safety and efficacy of panitumumab plus neoadjuvant chemotherapy in patients with primary HER2-negative inflammatory breast cancer. JAMA Oncol 4(9):1207-1213, 2018. e-Pub 2018. PMID: 29879283.
43. Menta A, Fouad TM, Lucci A, Le-Petross H, Stauder MC, Woodward WA, Ueno NT, Lim B. Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer. Surg Clin North Am 98(4):787-800, 2018. e-Pub 2018.
44. Candelaria RP, Hansakul P, Thompson AM, Le-Petross H, Valero V, Bassett R, Huang ML, Santiago L, Adrada BE. Analysis of stereotactic biopsies performed on suspicious calcifications identified within 24 months after completion of breast conserving surgery and radiation therapy for early breast cancer: Can biopsy be obviated?. Am J Surg 17(4):30237‐4, 2018. e-Pub 2018. PMID: 28712671.
45. Le-Petross HT, McCall LM, Hunt KK, Mittendorf EA, Ahrendt GM, Wilke LG, Ballman KV, Boughey JC. Axillary ultrasound identifies residual nodal disease after chemotherapy: Results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). AJR Am J Roentgenol 210(3):1-8, 2018. e-Pub 2018. PMID: 29381381.
46. DeSnyder SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, Whitman GJ, Ueno NT, Woodward WA, Kuerer HM, Akay CL, Babiera GV, Yang W, Lucci A. Prospective feasibility trial of sentinel lymph node biopsy in the setting of inflammatory breast cancer. Clin Breast Cancer 18(1):e73-e77, 2018. e-Pub 2018. PMID: 28755879.
47. Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. International consensus on the clinical management of inflammatory breast cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer 9(8):1437-1447, 2018. e-Pub 2018. PMID: 29721054.
48. Woodward WA, Fang P, Arriaga L, Gao H, Cohen EN, Reuben JM, Valero V, Le-Petross H, Middleton LP, Babiera GV, Strom EA, Tereffe W, Hoffman K, Smith BD, Buchholz TA, Perkins GH. A Phase II Study of Preoperative Capecitabine and Concomitant Radiation in Women With Advanced Breast Cancer. Int J Radiat Oncol Biol Phys 99(4):777-783, 2017. e-Pub 2017. PMID: 28843370.
49. Le-Petross HT, Hess KR, Knudtson JD, Lane DL, Moseley TW, Geiser WR, Whitman GJ. Effect of Mammography on Marker Clip Migration After Stereotactic-Guided Core Needle Breast Biopsy. Curr Probl Diagn Radiol 46(6):410-414, 2017. e-Pub 2017. PMID: 28390794.
50. Raghavendra A, Sinha AK, Le-Petross HT, Garg N, Hsu L, Patangan M, Bevers TB, Shen Y, Banu A, Tripathy D, Bedrosian I, Barcenas CH. Mammographic breast density is associated with the development of contralateral breast cancer. Cancer 123(11):1935-1940, 2017. e-Pub 2017. PMID: 28135395.
51. Simmons RM, Ballman KV, Cox C, Carp N, Sabol J, Hwang RF, Attai D, Sabel M, Nathanson D, Kenler A, Gold L, Kaufman C, Han L, Bleznak A, Stanley Smith J, Holmes D, Fornage B, Le-Petross C, Hoda S, McCall L, Hunt KK, investigators A. A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072. Ann Surg Oncol 23(8):2438-45, 2016. e-Pub 2016. PMID: 27221361.
52. Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Feliberti EC, Hunt KK. Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance). Ann Surg 263(4):802-7, 2016. e-Pub 2016. PMID: 26649589.
53. Bedrosian I, Xing Y, Abdel Rahman S, Allen L, Le-Petross H, Whitman GJ, Meric-Bernstam F, Hunt KK, Babiera GV, Cormier JN. A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer. Ann Surg Oncol 23(1):23-9, 2016. e-Pub 2016. PMID: 26156655.
54. Boughey JC, Ballman KV, Hunt KK, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Le-Petross HT. Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance). J Clin Oncol, 2015. e-Pub 2015. PMID: 25646192.
55. Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Yi M, Bedrosian I, Krishnamurthy S, Fornage BD, Hunt KK, Mittendorf EA. Predicting the Extent of Nodal Disease in Early-Stage Breast Cancer. Ann Surg Oncol 11(11):3440-7, 2014. e-Pub 2014. PMID: 24859939.
56. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCall L, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Nelson H, Hunt KK, in Oncology AFCT. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310(14):1455-61, 2013. e-Pub 2013. PMID: 24101169.
57. Dogan BE, Le-Petross CH, Stafford JR, Atkinson N, Whitman GJ. MRI-Guided Vacuum-Assisted Breast Biopsy Performed at 3 T With a 9-Gauge Needle: Preliminary Experience. AJR Am J Roentgenol 199(5):W651-3, 2012. e-Pub 2012. PMID: 23096211.
58. Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The Role for Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer. Ann Surg Oncol 19(10):3177-84, 2012. e-Pub 2012. PMID: 22772869.
59. Litton JK, Ready K, Chen H, Gutierrez-Barrera A, Etzel CJ, Meric-Bernstam F, Gonzalez-Angulo AM, Le-Petross H, Lu K, Hortobagyi GN, Arun BK. Earlier age of onset of BRCA mutation-related cancers in subsequent generations. Cancer 118(2):321-5, 2012. e-Pub 2012. PMID: 21913181.
60. Haygood TM, Arribas E, Liu QM, Atkinson EN, Brennan PC, Santiago L, Carkaci S, Lane D, Stephens TW, LePetross H, Adrada B, Davis P, Whitman GJ. Detection of microcalcifications on digital screening mammograms using varying degrees of monitor zooming. AJR 197(4):W761-8, 2011. e-Pub 2011. PMID: 21940549.
61. Le-Petross HT, Cristofanilli M, Carkaci S, Krishnamurthy S, Jackson EF, Harrell RK, Reed BJ, Yang WT. MRI Features of Inflammatory Breast Cancer. AJR Am J Roentgenol 197(4):W769-76, 2011. e-Pub 2011. PMID: 21940550.
62. Le-Petross HT, Whitman GJ, Atchley DP, Yuan Y, Gutierrez-Barrera A, Hortobagyi GN, Litton JK, Arun BK. Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer. Cancer 117(17):3900-7, 2011. e-Pub 2011. PMID: 21365619.
63. Cohen L, Chen Z, Arun B, Shao Z, Dryden M, Xu L, Le-Petross C, Dogan B, McKenna BJ, Markman M, Babiera G. External qigong therapy for women with breast cancer prior to surgery. Integr Cancer Ther 9(4):348-53, 2010. e-Pub 2010. PMID: 21106615.
64. Dominici LS, Negron Gonzalez VM, Buzdar AU, Lucci A, Mittendorf EA, Le-Petross HT, Babiera GV, Meric-Bernstam F, Hunt KK, Kuerer HM. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer 116(12):2884-9, 2010. e-Pub 2010. PMID: 20564395.
65. Le-Petross H, Hylton N. Role of Breast MR imaging in Neoadjuvant Chemotherapy. Magn Reson Imaging Clin N Am 18(2):249-58, viii-ix, 2010. e-Pub 2010. PMID: 20494310.
66. Le-Petross H, Kundra V, Szklaruk J, Wei W, Hortobagyi GN, Ma J. Fast three-dimensional dual echo dixon technique improves fat suppression in breast MRI. J Magn Reson Imaging 31(4):889-94, 2010. e-Pub 2010. PMID: 20373433.
67. Silberfein EJ, Hunt KK, Broglio K, Shen J, Sahin A, Le-Petross H, Oh J, Litton J, Hwang RF, Mittendorf EA. Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma. Clin Breast Cancer 10(1):52-8, 2010. e-Pub 2010. PMID: 20133259.
68. Carkaci S, Macapinlac HA, Cristofanilli M, Mawlawi O, Rohren E, Gonzalez Angulo AM, Dawood S, Resetkova E, Le-Petross HT, Yang WT. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J Nucl Med 50(2):231-8, 2009. e-Pub 2009. PMID: 19164229.
69. Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken BS, Le-Petross H, Fornage BD, Bassett RL, Hunt KK. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study. AJR Am J Roentgenol 191(3):646-52, 2008. e-Pub 2008. PMID: 18716089.
70. Yang WT, Lane DL, Le-Petross HT, Abruzzo LV, Macapinlac HA. Breast lymphoma: imaging findings of 32 tumors in 27 patients. Radiology 245(3):692-702, 2007. e-Pub 2007. PMID: 17911538.
71. Ma J, Son JB, Zhou Y, Le-Petross H, Choi H. Fast spin echo triple echo Dixon (fTED) technique for efficient T2-weighted water and fat imaging. Magn Reson Med 58(1):103-109, 2007. e-Pub 2007. PMID: 17659631.
72. Le-Petross HT. Breast MRI as a screening tool: the appropriate role. J Natl Compr Canc Netw 4(5):523-526, 2006. e-Pub 2006. PMID: 16687098.
73. Kwan AL, Boone JM, Le-Petross HT, Lindfors KK, Seibert JA. Contrast-enhanced dual-energy digital subtraction mammography: optimization of the beam energy. Proc Soc Photo Opt Instrum Eng 5745, 2005. e-Pub 2005.
74. Reddy NM, Gerscovich EO, Jain KA, Le-Petross HT, Brock JM. Vasectomy-related changes on sonographic examination of the scrotum. J Clin Ultrasound 32(8):394-398, 2004. e-Pub 2004. PMID: 15372447.
75. Le-Petross HT, Patel MD, Roberts CC, Liu PT, Karstaedt PJ. Magnetic resonance imaging estimation of breast cancer size after large core needle biopsy. Journal of Women's Imaging 16:160-165, 2004. e-Pub 2004.
76. Harnett J, Le H. Cardiovascular effects of erythropoietin. Dial Transplant 22(9), 1993. e-Pub 1993.
77. Harnett J, Le H. Importance of blood pressure control in dialysis patients receiving erythropoietin. J Am Soc Nephrol 3(3):426, 1992. e-Pub 1992.
78. Belitsky B, Ellsmere L, Le H, Sketris I. Relationship of cyclosporine clearance to demographic and outcome variables in kidney transplant patients, 1990. e-Pub 1990.
79. Schalck DA, Tran T, Li J, Sei DE, Bai MS, Hu DM, Lin MJ, Bright DS, Reddick MS, Yang DF, Batra DH, Contreras DA, Gabriela Raso DM, Stauder DM, Hoffman DK, Reddy DJ, Nead DK, Smith DB, Sawakuchi DG, Woodward W, Watowich DS, Litton DJ, Bedrosian DI, Mittendorf DE, Le-Petross DH, Shaitelman DS. The Impact of Breast Radiotherapy on the Tumor Genome and Immune Ecosystem. Nature Genetics.
80. Schalck A, Tran T, Li J, Sei E, Bai S, Hu M, Lin J, Bright SJ, Reddick S, Yang F, Batra H, Contreras A, Raso MG, Stauder MC, Hoffman KE, Reddy JP, Nead KT, Smith BD, Sawakuchi GO, Woodward WA, Watowich SS, Litton JK, Bedrosian I, Mittendorf EA, Le-Petross H, Navin N, Shaitelman SF. The Impact of Breast Radiotherapy on the Tumor Genome and Immune Ecosystem. Cancer Cell.
81. Le-Petross H. Tumor necrosis in triple-negative breast cancer (TNBC) on pretreatment dynamic contrast-enhanced MRI is not associated with response to neoadjuvant systemic therapy. Radiology.
82. Navin N, Schalck A, Tran T, Li J, Sei E, Bai S, Hu M, Lin J, Bright DS, Reddick MS, Yang DF, Batra DH, Contreras DA, Gabriela Raso DM, Stauder DM, Hoffman DK, Reddy DJ, Nead DK, Smith DB, Sawakuchi DG, Woodward W, Watowich DS, Litton DJ, Bedrosian I, Mittendorf E, Le-Petross H, Shaitelman S. The Impact of Breast Radiotherapy on the Tumor Genome and Immune Ecosystem. Nature Genetics.

Invited Articles

1. Le-Petross H, Uppendahl L, Stafford R. Sonographic appearance of inflammatory breast cancer. Seminars in Roentgenology 46(4):275-279, 2011. e-Pub 2011.
2. Le-Petross HT, Shetty MK. Magnetic resonance imaging and breast ultrasonography as an adjunct to mammographic screening in high-risk patients. Semin Ultrasound CT MR 32(4):266-272, 2011. e-Pub 2011. PMID: 21782116.
3. Le-Petross H, Lane D. Challenges and potential pitfalls in magnetic resonance imaging of more elusive breast carcinomas. Semin Ultrasound CT MR 32(4):342-350, 2011. e-Pub 2011. PMID: 21782124.
4. Le-Petross HT, Stafford RJ. The Need for MRI before breast-conserving surgery. Current Breast Cancer Reports 1:98-103, 2009. e-Pub 2009.
5. Le-Petross CH, Bidaut L, Yang WT. Evolving role of imaging modalities in inflammatory breast cancer. Semin Oncol 35(1):51-63, 2008. e-Pub 2008. PMID: 18308146.
6. Le-Petross HT. Breast MRI screening. Oncolog 52(12):8, 2007. e-Pub 2007.

Manuals, Teaching Aids, Other Teaching Publications

1. Candelaria RP, Le-Petross H. November Case of the Month. Society of Breast Imaging, 2010.
2. Le H. Students attitudes towards health care system, 1992.
3. Le H. Antiemetics. The Ottawa Valley Regional Drug Information Service Publication, 1991.

Other Articles

1. Le-Petross HT, Sadia Saleem, Megha Kapoor, Susie Sun, MD Anderson Inflammatory Breast Cancer, Wendy Woodward Comprehensive Review of Clinical Presentation, Multimodality Imaging, and Therapeutic Strategies for Inflammatory Breast Cancer. Applied Radiology.
2. Wang X, Zhao L, Song X, Wu X, Krishnamurthy S, Semba T, Shao S, Knafl M, Larry W Coffer II, Alexander A, Vines A, Bopparaju S, Woodward WA, Chu R, Zhang J, Yam C, M Loo LW, Nasrazadani A, Huong L, Woodman SE, Futreal A, Initiative Team RT, Tripathy D, Ueno NT Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer. Nature, 2024.
3. Patel, MM, Le-Petross, H, Kapoor, MM, Farag, JA, Whitman, GJ, Guirguis, MS Current Imaging Approaches in Inflammatory Breast Cancer. Current Breast Cancer Reports 16(2):142-149, 2024.
4. Le-Petross HT, Balema W, Woodward WA Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges: a narrative review. Chin Clin Oncol 10(6):58, 2021. PMID: 35016512.
5. Abdelhafez AH, Musall BC, Adrada BE, Hess K, Son JB, Hwang KP, Candelaria RP, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, Arribas E, Lane DL, Scoggins ME, Leung JWT, Mahmoud HS, White JB, Ravenberg EE, Litton JK, Valero V, Wei P, Thompson AM, Moulder SL, Pagel MD, Ma J, Yang WT, Rauch GM Tumor necrosis by pretreatment breast MRI: Association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC). Breast Cancer Res Treat 185(1):1-12, 2021. PMID: 32920733.
6. Karbasian N, Sohrabi S, Omofoye TS, Le-Petross H, Arun BK, Albarracin CT, Hess KR, Gutierrez-Barrera AM, Whitman GJ Imaging features of triple negative breast cancer and the effect of BRCA mutations. Curr Probl Diagn Radiol 50(3):303-307, 2021. PMID: 32033821.
7. Menta A, Fouad TM, Lucci A, Le-Petross H, Stauder MC, Woodward WA, Ueno NT, Lim B Inflammatory breast cancer: What to know about this unique, aggressive breast cancer. Surg Clin North Am 98(4):787-800, 2018. PMID: 30005774.
8. Le-Petross HT, Lim B Role of MR Imaging in neoadjuvant therapy monitoring. Magn Reson Imaging Clin N Am 26(2):207-220, 2018. PMID: 29622126.
9. Lahat G, Lev D, Gerstenhaber F, Madewell J, Le-Petross H, Pollock RE Sarcomas of the breast. Expert Rev Anticancer Ther 12(8):1045-51, 2012. PMID: 23030224.
10. Robertson FM, Bondy M, Yang W, Yamauchi H, Wiggins S, Kamrudin S, Krishnamurthy S, Le-Petross H, Bidaut L, Player AN, Barsky SH, Woodward WA, Buchholz T, Lucci A, Ueno NT, Ueno N, Cristofanilli M Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin 60(6):351-75, 2010. PMID: 20959401.
11. Yang WT, Le-Petross HT, Macapinlac H, Carkaci S, Gonzalez-Angulo AM, Dawood S, Resetkova E, Hortobagyi GN, Cristofanilli M Inflammatory breast cancer - PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 109(3):417-426, 2008. PMID: 17653852.

Editorials

1. Le-Petross H. MR-Directed ("Second-Look") Ultrasound Examination for Breast Lesions Detected Initially on MRI: MR and Sonographic Findings. Year Book of Diagnostic Radiology 2011:56-57, 2011.
2. Solin L, Le-Petross HT. Early stage breast cancer: should MRI factor into conservation surgery, mastectomy or bilateral mastectomy?. HemOnc Today, Clinical News on Hematology and Oncology, 2008.

Abstracts

1. Le-Petross HT, Scoggins ME, Adrada BE. Safety of Breast MRI under General Anesthesia. 2022 San Antonio Breast Cancer Symposium, 2022. e-Pub 2022.
2. Marx AN, Kai M, Fu M, Murphy HE, Willey JS, Sun H, Alexander A, Bassett RL, Whitman G, Le-Petross H, Patel M, Woodward W, Lucci A, Arun B, Abouharb S, Thomas P, Barcenas CH, Booser DJ, Ibrahim NK, Valero V, Ueno NT, Layman RM, Lim B. A phase 1b study of neratinib with THP in metastatic and locally advanced breast cancer, and phase II study of THP followed by AC in HER2 + primary inflammatory breast cancer (IBC), and neratinib with Taxol followed by AC in HR+ /HER2- primary IBC. San Antonio Breast Cancer Symposium 2022. e-Pub 2022.
3. pending. Long-term Outcomes After 1 or 2-3 Lines of Neoadjuvant Therapy in Stage III Inflammatory Breast Cancer. 2022 San Antonio Breast Cancer Symposium Abstract. e-Pub 2022.
4. Piotrowski MJ, Yi M, Contreras A, Hunt KK, Hwang RF, Kuerer HM, Le-Petross H, Teshome M, Underbrink A, DeSnyder SM. Optimization of Intraoperative Lumpectomy Specimen Labeling. ASBS 2020. e-Pub 2020.
5. Rosenkranz KM, Ballman K, McCall L, Kubicky C, Cuttino L, Le-Petross H, Hunt KK, Haffty B, Boughey JC. The feasibility of breast-conserving surgery for multiple ipsilateral breast cancer: An initial report from ACOSOG (Alliance) Z11102 trial. American Society of Breast Surgeons, 2018. e-Pub 2018.
6. Raghavendra A, Wei W, Candelaria RP, Tripathy D, Bedrosian I, Barcenas C, Le-Petross H. Characteristics of contralateral breast cancer among women with a first breast cancer. Global Academic Programs GAP 2018 conference. e-Pub 2018.
7. Eghtedari M, MD, PhD, Le-Petross H, MD, Babiera GV, MD, Albarracin CT, MD, PhD, Hess KR, PhD, Whitman GJ, MD. MRI-Guided Needle Localization: Case-Based Primer. ARRS Syllabus(E3013). e-Pub 2017.
8. Hansakul P, Candelaria RP, Le-Petross HC, Huang ML, Santiago L, Adrada BE. Analysis of stereotactic biopsies performed on calcifications identified after recent completion of breast conserving therapy: Can biopsy be obviated?. Radiological Society of North America 102nd Scientific Assembly and Annual Meeting, 2016. e-Pub 2016.
9. Le-Petross H, Wolfe A, Allen P, Rohren E, Landry L, Leung J, Woodward W. Correlate Foamy Macrophages and FDG at PET in IBC. 116th Annual Meeting of the ARRS syllabus. e-Pub 2016.
10. Raghavendra AS, Sinha AK, Tripahty D, Bedrosian I, Le-Petross HL, Barcenas CH. Association Between Mammographic Breast Density (BD) and the Development of a Second Contralateral Breast Cancer (CBC): A Nested Case-control Study. SSO's 69th Annual Cancer Symposium. e-Pub 2016.
11. Raghavendra A, Sinha AK, Hsu L, Patangan M, Le-Petross HT, Bevers TB, Tripathy D, Bedrosian I, Barcenas CH. Association between tumor stage of first non-metastatic breast cancer and second contralateral breast cancer. Cancer Survivorship Symposium: Advancing Care and Research(ID 157550). e-Pub 2016.
12. Raj SD, Kalambo MJ, Dogan BE, Le-Petross H, Whitman G. MRI-Guided Needle Localization: Case-Based Primer. ARRS 116 Syllabus, 2016. e-Pub 2016.
13. Desnyder S, H Le-Petross AA, Lucci A. Prospective Study of the Feasibility of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer. ASBS, 2016. e-Pub 2016.
14. Eghtedari M, MD, PhD, Le-Petross H, MD, Babiera GV, MD, Albarracin CT, MD, PhD, Hess KR, PhD, Whitman GJ, MD. : Imaging-detected radial scars without associated atypia, LCIS, or papilloma may not require surgical excision. RSNA Syllabus(ID: 15047615), 2015. e-Pub 2015.
15. Candelaria R, MD, Houston, TX, Huang M, MD, Adrada B, MD, Arribas E, MD, Scoggins M, MD, Yang W, MD, et al. Comparing the Performance of Full-Field Digital Mammography (FFDM), Digital Breast Tomosynthesis (DBT) and Whole Breast Ultrasound (WBUS) in the Initial Staging Evaluation of Breast Cancer: Interim Results of a Prospective Study. RSNA Syllabus. e-Pub 2015.
16. Rao A, Net J, Brandt K, Huang E, Freymann J, Burnside E, Kirby J, Morris E, Bonaccio E, Giger M, Jaffe C, Ganott M, Sutton E, Le-Petross H, Zuley M, Dogan B, Whitman G. TU-CD-BRB-07: Identification of Associations Between Radiologist-Annotated Imaging Features and Genomic Alterations in Breast Invasive Carcinoma, a TCGA Phenotype Research Group Study. Med Phys. 2015 Jun;42(6):3603 42(6):3603, 2015. e-Pub 2015.
17. Le-Petross HC, McCall LM, Hunt KK, Mittendorf E, Ahrendt GM, Wilke LG, Boughey J. Correlation of axillary ultrasound features after neoadjuvant chemotherapy with final pathology in patients presenting with node-positive breast cancer (T0-T4, N1-2, M0): Results from a multi-institutional collaborative clinical trial (Alliance). Radiological Society of North America 100th Scientific Assembly and Annual Meeting, 2014. e-Pub 2014.
18. Santiago L, Eghtedari M, Le-Petross H. Mastering the challenges of MRI-guided breast interventions; MRI-guided biopsy and beyond. Radiological Society of North America 100th Scientific Assembly and Annual Meeting, 2014. e-Pub 2014.
19. Boughey JC, Ballman KV, Hunt KK, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Le-Petross HT. Axillary Ultrasound After Neoadjuvant Chemotherapy in Patients Presenting with Node-Positive Breast Cancer (T0-T4,N1-2,M0) and its Impact on Sentinel Lymph Node Surgery in ACOSOG Z1071 (ALLIANCE). 18th SIS World Congress on Breast Healthcare, 2014. e-Pub 2014.
20. Woodward WA, Arriaga L, Gao H, Cohen EN, Li L, Reuben JM. Prosepctive phase II study of concurrent capecitabine and radiation demonstrates futility in triple negative chemo-resistant breast cancer. Cancer Research(73):08, 2013. e-Pub 2013.
21. Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Bedrosian I, Krishnamurthy S, Lucci A, Hunt KK, Mittendorf EA. Predicting the extent of nodal disease in early breast cancer. Breast Cancer Symposium 2013, 2013. e-Pub 2013.
22. Le-Petross HT, Caudle AS, Lari SA, Yang WT, Hunt KK, Alvarez RH, Krishnamurthy S, Kuerer HM. Nodal Ultrasound Reliability Varies with Molecular Subtypes in Breast Cancer after Neoadjuvant Chemotherapy. ARRS 2013 Meeting, 2013. e-Pub 2013.
23. Cure LM, Garvey P, Sagebiel T, Baumann D, Iyer R, Madewell J, Le-Petross H. Role of CT and MR Angiography in Preoperative Planning of Reconstructive Surgery. Electronic Exhitib E480, 2013. e-Pub 2013.
24. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B. The role of sentinel lymph node surgery in patients presenting with node positive breast cancer who received neoadjuvant chemotherapy: Z1071. Cancer research 72(24):7s, 2012. e-Pub 2012.
25. Martaindale S, Hobbs B, Yang WT, Albarez RH, Krishnamurthy S, Le-Petross HC. Assessment of residual disease using mammography (MG), sonography (US), and magnetic resonance imaging (MRI) in patients (pts) with inflammatory breast cancer (IBC) who received neoadjuvant chemotherapy (NAC). Radiological Society of North America 98th Scientific Assembly and Annual Meeting, 2012. e-Pub 2012.
26. Alvarado R, MD, Yi M, MD, Le-Petross H, MD, Gilcrease M, MD, Mittendorf EA, MD, Bedrosian I, MD, Hwang RF, MD, Caudle AS, MD, Babiera GV, MD, Akins JS, PA, Kuerer HM, MD, PhD, K Hunt AK, MD. Is Sentinel Lymph Node Biopsy Accurate after Neoadjuvant Chemotherapy in Patients who Present with Node Positive Breast Cancer?, 2012. e-Pub 2012.
27. Berg WA, Mendelson EB, LePetross H, Zhang Z, Marques H, Adams A. Reasons for failed cancer detection in the ACRIN 6666 screening protocol: Mammography, US, MRI. Radiological Society of North America 97th Scientific Assembly and Annual Meeting, 2011. e-Pub 2011.
28. Whitman G, Le-Petross H, Dogan B, Adrada B, Stafford R. Tissue harmonic imaging in breast ultrasound: Help or hinderance. Radiological Society of North America 97th Scientific Assembly and Annual Meeting, 2011. e-Pub 2011.
29. Winston E, Le-Petross H, Cristofanilli M, Gong Y, Yang W. Inflammatory Breast Carcinoma (IBC): Imaging Findings on Mammography, US,. American Roentgen Ray Society 110th meeting:74, 2010. e-Pub 2010.
30. Boughey JC, Suman V, Le-Petross C, Haffty B, Leitch M, Ollila D, Byrd D, Buchholz T, Symmans W, Hunt KK. A Phase II Study Evaluating the Role of Sentinel Lymph Node. ASCO, 2010. e-Pub 2010.
31. Deleonardis C, Lodhi A, Le-Petross H, singh. Pleomorphic Calcifications, Tumor Markers, and Response to Therapy. Cancer Research(69):2027, 2009. e-Pub 2009.
32. Dominici LS, Negron Gonzalez VM, Buzdar AU, Lucci A, Mittendorf EA, Pusztai L, Krishnamurthy S, Le-. Eradication of Axillary Lymph Node Metastases Occurs in 74% of Patients Receiving Neoadjuvant. San Antonio Breast Cancer Symposium 2009, 2009. e-Pub 2009.
33. DeLeonardis CA, Lodhi AK, Le-Petross H, Singh B, Krishnamurthy S, Lucci A. Pleomorphic Calcifications, Tumor Markers, and Response to Therapy, 2009. e-Pub 2009.
34. Le-Petross H, Kundra V, Szklaruk J, Wei W, Andreopoulou E, Jingfei M. Fat Suppression for Breast MRI Improves by Fast 3D Dual Echo Dixon Technique. ARRS 109th Annual Meeting, 2009. e-Pub 2009.
35. Ai H, Taylor B, Elliott A, Le-Petross H, Hazle J, Stafford R. Initial Evaluation of a Fast Chemical Shift Thermometry Technique in Breast. ISMRM 17th Scientific Meeting, 2009. e-Pub 2009.
36. Le-Petross HT, Atchley DP, Whitman GJ, Hortobagyi GN, Arun BK. Effectiveness of screening women at high risk for breast cancer with alternating mammography and MRI. ARRS 109th Annual Meeting, 2009. e-Pub 2009.
37. Le-Petross HT, Cristofanilli M, Qing Y, Jackson EF, Gong Y, Reed B, Hortobagyi GN, Yang WT. Inflammatory breast cancer: defining breast magnetic resonance imaging features. 31st Annual San Antonio Breast Cancer Symposium, 2008. e-Pub 2008.
38. Le-Petross HT, Atchley DP, Whitman GJ, Hortobagyi GN, Arun BK. Effectiveness of screening women at high risk for breast cancer with alternating mammography and MRI. 31st Annual San Antonio Breast Cancer Symposium, 2008. e-Pub 2008.
39. Yuan Q, Whitman G J, Le-Petross HT, Cristofanilli M, Andreopoulou E, Jackson EF. Noninvasive 3.0T DWI, MRS, and DCE-MRI techniques for early assessment of response to neoadjuvant chemotherapy in locally advanced breast cancer. Radiological Society of North America 94th Scientific Assembly and Annual Meeting, 2008. e-Pub 2008.
40. Le-Petross HT, Whitman G, Dempsey P, Johnson VE, Geiser WR, Lindfors KK. The effect of postprocedure mammography on clip marker migration after vacuum-assisted stereotactic biopsy. Radiological Society of North America 94th Scientific Assembly and Annual Meeting, 2008. e-Pub 2008.
41. Reed BJ, McAlee KR, Yuan Q, Jackson EF, Whitman GJ, Le-Petross HT. Utilizing BREASE (Breast Spectroscopy Exam) to monitor neoadjuvant chemotherapy response at 3T preliminary results. Society of Magnetic Resonance in Medicine 16th Scientific Meeting and Exhibition, 2008. e-Pub 2008.
42. Le-Petross HT, Charnsangavej C, Cristofanilli M, Yuan Q PHD, Yang WT. Inflammatory breast cancer (IBC): magnetic resonance imaging (MRI) characteristics at 1.5 and 3.0T. Radiological Society of North America 93rd Scientific Assembly and Annual Meeting, 2007. e-Pub 2007.
43. Le-Petross HT, Carkaci S, Stafford R, Elliott A, Jackson E. 1.5 and 3.0 T magnetic resonance imaging artifacts from breast biopsy clip. Am J Roentgenol Supplement 188:A87-99, 2007. e-Pub 2007.
44. Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken B, Le-Petross H, Hunt K, Feig BW, Singletary SE, Ross MI, Ames FC, Bedrosian I, Meric F, Kuerer HM, Fornage BD. Cortical morphology of axillary lymph nodes as a predictor of metastatic disease in breast cancer: an in-vitro ultrasound study. Am J Roentgenol Supplement 186:A79, 2006. e-Pub 2006.
45. Roberts CC, Le-Petross HT, Karstaedt PJ, Liu PT. Unusual appearances of benign and malignant disease on breast MRI. Silver Medal, Scientific Exhibits Award. AJR Am J Roentgenol, 2003. e-Pub 2003.
46. pending. Tumor segmentation with nnU-Net on dynamic contrast enhanced MR images of triple negative breast cancer. ISMRM 2023.
47. Wood M, Seisler DK, Hsieh M, Kontos D, Ambaye AB, Le-Petross HT, Jung S, Liu H, Zekan PJ, Cardinal L, Charlamb J, Wang LX, Unzeitig GW, Garber JE, Marshall JR. Influence of vitamin D (Vit D) on mammographic density (MD) and insulin like growth factor 1 (IGF1): results of CALGB (Alliance) 70806. JCO.
48. Alexander A, Willey J, Sun H, Parker C, Marx A, Wood A, Reddy SM, Reuben JM, Bassett R, Le-Petross HT, Krishnamurthy S, Gong Y, Woodward W, Valero V, Ueno NT, Lim B, . A single arm phase II study of adjuvant anti-PD1 (pembrolizumab) in combination with hormonal therapy in patients with hormone receptor (HR)-positive localized inflammatory breast cancer (IBC) who did not achieve a pathological complete response (pCR) to neoadjuvant chemotherapy.
49. Ma, Jingfei, Le-Petross, HT. Deep Learning Using Pre-treatment MRIs and Clinical Information for Prediction of Pathological Complete Response to Neoadjuvant Systemic Therapy in Triple Negative Breast Cancer. RSNA.

Book Chapters

1. Le-Petross, H, Stafford, RJ, Bedrosian, I, Garvey, PB, Woodward, W, Moulder-Thompson, SL. Breast Cancer, 476-502, 2022.
2. Le-Petross H, Lim B, Hylton N. Magnetic Resonance Imaging and Neoadjuvant Chemotherapy. In: Breast Oncology: Techniques, Indications, and Interpretation. Springer Science+Business Media, 2016.
3. Le-Petross H, Caudle A. Chapter 15: Staging of Breast Cancer. In: Breast Cancer Screening and Diagnosis. 1st Ed. Springer Science + Business Media, 301-314, 2015.
4. Le-Petross HT, Stafford RJ, Morris EA. Breast MRI. In: Advanced Therapy of Breast Disease. 3rd edition. PMPH-USA, 2012.
5. Le-Petross H, Stafford J, Bedrosian I, Garvey P, Woodward W, Moulder-Thompson S. Breast Cancer. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier Saunders, 479-508, 2012.
6. Le-Petross H, Stephens T. Current Status of Computer-Aided Detection of Breast Cancer. In: Physics of Mammographic Imaging. 1st. Taylor and Francis, 165-174, 2012.
7. Le-Petross H. Stereotactic Guided Breast Biopsy. In: Breast Surgical Oncology. 1st. McGraw-Hill, 2010.
8. Le-Petross H. Ultrasound Examination of the Breast and Fine-Needle Aspiration. In: Kuerer's Breast Surgical Oncology. 1st. McGraw-Hill COmpanies Inc, 2010.
9. Singletary SE, Middleton LA, Le-Petross HT. Chapter 85: The unknown primary presenting with axillary lymphadenopathy. In: The Breast. 4th. Saunders - Elvsevier, 1373, 2009.
10. Lindfors K, Le-Petross H. Breast Imaging. In: Fundamentals of Diagnostic Radiology. Third. Lippincott Williams and Wilkins, 565-600, 2007.
11. Lindfors K, Le-Petross HT. Chapter 20: Breast imaging. In: Fundamentals of Diagnostic Radiology. 3rd. Lippincott Williams & Wilkins, 565-600, 2006.

Letters to the Editor

1. Rosenkranz KM, Ballman K, McCall L, Kubicky CD, Cuttino L, Le-Petross H, Hunt K, Giuliano A, Van Zee K, Haffty B, Boughey J. Reply to "Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report". Ann Surg Oncol 26: 702, 2019.
2. Yang WT, Le-Petross HT. Response to Preda L, Rizzo S, Bellomi M - Breast lymphoma: Imaging findings of 32 tumors in 27 patients. Radiology 248: 320, 2008.